Sp1 and Sp3 transcription factors synergistically regulate HGF receptor gene expression in kidney.
about
Dual role of Sp3 transcription factor as an inducer of apoptosis and a marker of tumour aggressivenessMefunidone attenuates tubulointerstitial fibrosis in a rat model of unilateral ureteral obstructionDifferential intranuclear organization of transcription factors Sp1 and Sp3.PAX3 and SOX10 activate MET receptor expression in melanoma.MicroRNA-124-3p inhibits cell migration and invasion in bladder cancer cells by targeting ROCK1.Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria.The identification of trans-acting factors that regulate the expression of GDF5 via the osteoarthritis susceptibility SNP rs143383.Wild-type p53 controls cell motility and invasion by dual regulation of MET expressionhepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists.Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction.Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action.Gene regulation by Sp1 and Sp3.GSTA3 Attenuates Renal Interstitial Fibrosis by Inhibiting TGF-Beta-Induced Tubular Epithelial-Mesenchymal Transition and Fibronectin Expression.Differential effects of Sp cellular transcription factors on viral promoter activation by varicella-zoster virus (VZV) IE62 proteinDeleting the TGF-β receptor in proximal tubules impairs HGF signalingActivation of hepatocyte growth factor receptor, c-met, in renal tubules is required for renoprotection after acute kidney injury.Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met.Sp1 trans-activates the murine H(+)-K(+)-ATPase alpha(2)-subunit gene.Signal transduction in podocytes--spotlight on receptor tyrosine kinases.Regulation of the Na-K-ATPase beta(1)-subunit promoter by multiple prostaglandin-responsive elements.Ring-Sp1 decoy oligonucleotide effectively suppresses extracellular matrix gene expression and fibrosis of rat kidney induced by unilateral ureteral obstruction.An intramolecular G-quadruplex structure formed in the human MET promoter region and its biological relevance.Chemopreventive effects of tolfenamic acid against esophageal tumorigenesis in rats.Transcriptional and post-transcriptional control of DNA methyltransferase 3B is regulated by phosphatidylinositol 3 kinase/Akt pathway in human hepatocellular carcinoma cell lines.Tolfenamic acid decreases c-Met expression through Sp proteins degradation and inhibits lung cancer cells growth and tumor formation in orthotopic mice.PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription.Gum mastic increases maspin expression in prostate cancer cells.Elevated expression of vascular endothelial growth factor correlates with increased angiogenesis and decreased progression-free survival among patients with low-grade neuroendocrine tumors.Synergistic role of specificity proteins and upstream stimulatory factor 1 in transactivation of the mouse carboxylesterase 2/microsomal acylcarnitine hydrolase gene promoter.Suppression of HGF receptor gene expression by oxidative stress is mediated through the interplay between Sp1 and Egr-1.Both Sp1 and Smad participate in mediating TGF-beta1-induced HGF receptor expression in renal epithelial cells.A novel G-quadruplex motif in the Human MET promoter region.Fluorofenidone attenuates tubulointerstitial fibrosis by inhibiting TGF-β(1)-induced fibroblast activation.Loss of phosphatase and tensin homolog enhances cell invasion and migration through AKT/Sp-1 transcription factor/matrix metalloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significance.
P2860
Q21143866-2442F228-14EB-4C78-A378-2A573D496325Q28547858-CCC7E1DC-DEAC-476B-BD9C-24E920584C3DQ33938359-D673DE1F-AD2B-4A18-81C0-71B4DD8DFA40Q34302054-08A7D9BD-AD05-4DBF-8E8E-EFAD99C6BB46Q34493584-81987BC8-43B2-4ABD-A070-B72D8E17E7FDQ34766590-9CE0291C-66EF-4C3A-B4C7-48D902A55A17Q34795530-E4C11867-39B5-4619-87C2-F3D9E6454521Q35180856-630A2F9B-6C8B-4BDB-A3DE-02F6F5CD45B5Q35677086-C82858FA-0D1F-468F-BD15-233A52B6F4A4Q35791678-B6A64142-B7BB-46D3-B199-A5FF5DF2DDEAQ35794379-6415FE98-5D2C-4552-80B4-E4948EBFBBB8Q35851299-2131A91B-CEAF-4B23-946D-920FD87F180FQ36125061-D2D800ED-B320-4105-9C6C-3DFDA29B9A50Q36202693-BB3CB680-A37D-4BCB-95DD-C89E53241EFEQ36698746-404DA66D-9C0F-46C3-88B5-03E282374289Q37136339-6E697584-71C3-4725-AE65-EC299E3FDAB8Q37246675-1E6EEA94-2BDD-4B72-A217-6A22E7586F94Q37264319-95FC10A0-C84F-48F2-B63F-D046E9EC32A0Q38176169-E504D412-A604-42D3-B70D-691048886B68Q38315804-9A7E9902-A30C-45C3-BFB2-C3E930284867Q38317847-1EB78338-46DC-4B2B-93D2-1EC870BCB6FCQ38878552-0169E7A2-F303-47FA-94BB-10E13D084B7BQ39613072-51497CF4-4138-4A9B-8CB9-2EB080AC3CF7Q39699541-5E276758-B132-4D58-8BE8-B4689D43F92CQ39784247-1BC0553D-35BF-4253-B6DE-9DCE923C93B8Q39896091-C4B145B0-2A59-4C18-9974-094FB2356E75Q40156040-E0900FB5-6492-4ACC-A1B3-6C4443668BFDQ40162867-3DA8DF05-1867-4122-B226-4C2D248938BDQ40530314-0AB698DE-597A-43D9-BFB8-C59D3261C79FQ40672745-BE2B2903-F128-4D6F-9F0E-411AAFE5523BQ45038535-711DFEA9-1A41-4CD4-A1A0-BEF811002E47Q47164810-836FE3E7-470F-465D-B29A-637E3666F1BEQ54571621-1428E551-EB2B-495D-B317-1A735D72CDC5Q54594283-456A1998-9F51-46D4-9491-79BD7B361217
P2860
Sp1 and Sp3 transcription factors synergistically regulate HGF receptor gene expression in kidney.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Sp1 and Sp3 transcription fact ...... tor gene expression in kidney.
@en
type
label
Sp1 and Sp3 transcription fact ...... tor gene expression in kidney.
@en
prefLabel
Sp1 and Sp3 transcription fact ...... tor gene expression in kidney.
@en
P2093
P2860
P1476
Sp1 and Sp3 transcription fact ...... tor gene expression in kidney.
@en
P2093
Chunsun Dai
Junwei Yang
Peter Mundel
Xianghong Zhang
Yingjian Li
Youhua Liu
P2860
P304
P356
10.1152/AJPRENAL.00200.2002
P577
2003-01-01T00:00:00Z